{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:10:16Z","timestamp":1779257416571,"version":"3.51.4"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Trousseau syndrome is a cancer-associated hypercoagulable state characterized by recurrent thromboembolic events, including ischemic stroke. Optimal anticoagulation strategies remain controversial, particularly regarding the effectiveness of direct oral anticoagulants (DOACs) compared with low-molecular-weight heparin (LMWH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report two patients with Trousseau syndrome who presented with recurrent multi-territory cerebral infarctions despite ongoing DOAC therapy. Case 1 was a 66-year-old man with active intrahepatic cholangiocarcinoma who developed repeated ischemic strokes and deep vein thrombosis while receiving rivaroxaban. After switching to LMWH, D-dimer levels decreased markedly. However, anticoagulation was de-escalated in the context of apparent normalization of D-dimer, followed by recurrent stroke, subsequent discontinuation of anticoagulation, and a rapid surge in D-dimer levels, ultimately resulting in death. Case 2 was a 74-year-old man with suspected recurrent metastatic gastric adenocarcinoma who developed ischemic stroke while on rivaroxaban. Following transition to LMWH, D-dimer levels progressively declined, and the patient remained clinically stable without recurrence during follow-up. A longitudinal timeline analysis integrating biomarker dynamics, treatment transitions, and clinical events demonstrated distinct patterns between the two cases, suggesting a potential discordance between D-dimer levels and underlying hypercoagulable activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These cases highlight the dynamic nature of hypercoagulability in Trousseau syndrome. Normalization of D-dimer alone may not reliably indicate sustained control of malignancy-associated hypercoagulability and should not be used in isolation to guide anticoagulation de-escalation. LMWH may provide more consistent control in selected high-risk patients, although causal inference cannot be established from this report.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1834397","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:39:08Z","timestamp":1779255548000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Trousseau syndrome presenting with recurrent multi-territory infarctions: a case report of two patients highlighting divergent outcomes and dynamic hypercoagulability under direct oral anticoagulants and low-molecular-weight heparin"],"prefix":"10.3389","volume":"13","author":[{"given":"Gangyu","family":"Ding","sequence":"first","affiliation":[{"name":"Department of Neurology, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences","place":["Shanghai, China"]},{"name":"Department of Neurology, Shanghai East Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meifen","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.10.022","article-title":"Predictive value of plasma (D)-dimer levels for cancer-related stroke: a 3-year retrospective study","volume":"23","author":"Guo","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1182\/blood-2006-10-053736","article-title":"Trousseau's syndrome: multiple definitions and multiple mechanisms","volume":"110","author":"Varki","year":"2007","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/jjco\/hyv165","article-title":"Trousseau's syndrome: cancer-associated thrombosis","volume":"46","author":"Ikushima","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1161\/STROKEAHA.112.658625","article-title":"Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology","volume":"43","author":"Schwarzbach","year":"2012","journal-title":"Stroke"},{"key":"B5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1172\/JCI18882","article-title":"Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas","volume":"112","author":"Wahrenbrock","year":"2003","journal-title":"J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1182\/blood-2011-07-368514","article-title":"Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome","volume":"118","author":"Shao","year":"2011","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e44959","DOI":"10.1371\/journal.pone.0044959","article-title":"Clues to occult cancer in patients with ischemic stroke","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5853\/jos.2019.02278","article-title":"Cancer-related stroke: an emerging subtype of ischemic stroke with unique pathomechanisms","volume":"22","author":"Bang","year":"2020","journal-title":"J Stroke"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1016\/j.mayocp.2022.09.003","article-title":"Ischemic stroke in patients with malignancy","volume":"97","author":"Sener","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"B10","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ana.25227","article-title":"Ischemic stroke in cancer patients: a review of an underappreciated pathology","volume":"83","author":"Navi","year":"2018","journal-title":"Ann Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ana.24325","article-title":"Association between incident cancer and subsequent stroke","volume":"77","author":"Navi","year":"2015","journal-title":"Ann Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e97696","DOI":"10.7759\/cureus.97696","article-title":"A case of Trousseau syndrome: a report detailing recurrent ischaemic strokes associated with metastatic pancreatic cancer and pulmonary embolisms despite treatment with direct oral anticoagulation","volume":"17","author":"Aung","year":"2025","journal-title":"Cureus"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1378\/chest.14-0402","article-title":"Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis","volume":"147","author":"Vedovati","year":"2015","journal-title":"Chest"},{"key":"B15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4103\/tcmj.tcmj_55_19","article-title":"Anticoagulants for cancer-associated ischemic stroke","volume":"31","author":"Hsu","year":"2019","journal-title":"Tzu Chi Med J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1160\/TH08-12-0832","article-title":"Anti-cancer properties of low-molecular-weight heparin: preclinical evidence","volume":"102","author":"Mousa","year":"2009","journal-title":"Thromb Haemost"},{"key":"B17","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1016\/S0049-3848(07)70138-X","article-title":"Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects","volume":"120","author":"Stevenson","year":"2007","journal-title":"Thromb Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Randomized comparison of low-molecular-weight heparin versus oral anticoagulant therapy for the prevention of recurrent venous thromboembolism in patients with cancer (CLOT) investigators, low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1182\/hematology.2024000552","article-title":"Trousseau syndrome: management of refractory VTE","volume":"2024","author":"Zwicker","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B20","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fneur.2018.00528","article-title":"Changes in serial D-dimer levels predict the prognoses of Trousseau's syndrome patients","volume":"9","author":"Ito","year":"2018","journal-title":"Front Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000535644","article-title":"D-dimer trends predict recurrent stroke in patients with cancer-related hypercoagulability","volume":"14","author":"Fujinami","year":"2024","journal-title":"Cerebrovasc Dis Extra"},{"key":"B22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5853\/jos.2016.00570","article-title":"Hypercoagulability and mortality of patients with stroke and active cancer: the OASIS-CANCER study","volume":"19","author":"Lee","year":"2017","journal-title":"J Stroke"},{"key":"B23","doi-asserted-by":"publisher","first-page":"868137","DOI":"10.3389\/fneur.2022.868137","article-title":"Post-treatment plasma D-dimer levels are associated with short-term outcomes in patients with cancer-associated stroke","volume":"13","author":"Nakajima","year":"2022","journal-title":"Front Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/STROKEAHA.118.022088","article-title":"Evaluation and treatment of a patient with recurrent stroke in the setting of active malignancy","volume":"50","author":"Neilson","year":"2019","journal-title":"Stroke"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.21037\/qims-23-1746","article-title":"Trousseau's syndrome caused by hepatocellular carcinoma: a case description and literature analysis","volume":"14","author":"Wang","year":"2024","journal-title":"Quant Imaging Med Surg"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e017559","DOI":"10.1161\/JAHA.120.017559","article-title":"Direct oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B27","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s11239-020-02055-1","article-title":"DOAC compared to LMWH in the treatment of cancer related-venous thromboembolism: a systematic review and meta-analysis","volume":"50","author":"Mai","year":"2020","journal-title":"J Thromb Thrombolysis"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1834397\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:39:10Z","timestamp":1779255550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1834397\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":27,"alternative-id":["10.3389\/fcvm.2026.1834397"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1834397","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"article-number":"1834397"}}